<p>Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain</p>Josep‐María Ribera, Cristina Díaz de Heredia, Alejandra de Andrés Saldaña et al.|ClinicoEconomics and Outcomes Research|2020Cited by 27